Armistice Capital »

Twist Bioscience Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Twist Bioscience Corp (TWST) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Twist Bioscience Corp

Tip: Access up to 7 years of quarterly data

All positions including Twist Bioscience Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Twist Bioscience Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 142k 102.88

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Twist Bioscience Corp

BlackRock
Artisan Partners Limited Partnership
FMR
ARK Investment Management
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Edgepoint Investment
William Blair Investment Management
Farallon Capital Management
Invesco
Geode Capital Management
Thrivent Financial for Lutherans
Goldman Sachs Group
D. E. Shaw & Co

View all funds holding Twist Bioscience Corp